SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001654954-17-010673
Filing Date
2017-11-14
Accepted
2017-11-14 17:25:39
Documents
5
Effectiveness Date
2017-11-14

Document Format Files

Seq Description Document Type Size
1 FORM S 8 acer_s8.htm S-8 108498
2 OPINION OF PILLSBURY WINTHROP SHAW PITTMAN LLP acer_ex51.htm EX-5.1 7126
3 CONSENT OF WOLF & COMPANY, P.C., INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM acer_ex231.htm EX-23.1 4642
4 CONSENT OF MALONEBAILEY, LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM acer_ex232.htm EX-23.2 4516
5 IMAGE acer_s8000.jpg GRAPHIC 2290
  Complete submission text file 0001654954-17-010673.txt   129385
Mailing Address 222 THIRD STREET SUITE #2240 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE #2240 CAMBRIDGE MA 02142 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-221566 | Film No.: 171203117
SIC: 2834 Pharmaceutical Preparations